B. Jugdutt

B. Jugdutt, Peter Ting, Ju Le Tan, 2010, The International journal of angiology : official publication of the International College of Angiology, Inc.

Changes in myocardial density during postinfarction healing: effect on estimation of in vivo left ventricular mass by echocardiographic imaging.

B. Jugdutt, W. Ford, A. Bhambhani, 1997, Canadian journal of physiology and pharmacology.

Myocardial infarction, oral contraception, cigarette smoking, and coronary artery spasm in young women.

B. Jugdutt, B. Jugdutt, S. Lee, 1983, American heart journal.

Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction

B. Jugdutt, H. Idikio, R. Uwiera, 2013, Molecular and Cellular Biochemistry.

Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction.

B. Jugdutt, 2002, Journal of the American College of Cardiology.

Early changes in collateral blood flow during myocardial infarction in conscious dogs.

L. Becker, G. Hutchins, B. Jugdutt, 1979, The American journal of physiology.

Abolition of Ischemic Response to Atrial Pacing Following Aortocoronary Bypass Surgery

B. Jugdutt, S. Lee, R. Taylor, 1976, Circulation.

Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-ε in acutely reperfused myocardial infarction in the dog

B. Jugdutt, Yi Xu, V. Menon, 2000 .

Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts

B. Jugdutt, R. Moudgil, Dinender Kumar, 2001, Journal of hypertension.

Angiotensin II and cardiomyocyte apoptosis in the SHR

B. Jugdutt, Dinender Kumar, 2001 .

ACE inhibition after myocardial infarction: can megatrials provide answers?

G. Ertl, B. Jugdutt, 1994, The Lancet.

Relationship Between Myocardial Infarct Size and Occluded Bed Size in the Dog: Difference Between Left Anterior Descending and Circumflex Coronary Artery Occlusions

L. Becker, G. Hutchins, B. Bulkley, 1983, Circulation.

Angiotensin II reduces infarct size and has no effect on post‐ischaemic contractile dysfunction in isolated rat hearts

B. Jugdutt, W. Ford, C. Robin Hiley, 2001, British journal of pharmacology.

The dog model of left ventricular remodeling after myocardial infarction.

B. Jugdutt, 2002, Journal of cardiac failure.

Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril.

B. Jugdutt, H. Idikio, Dinender Kumar, 2002, Journal of the American College of Cardiology.

Consensus recommendations for the management of chronic heart failure: Introduction

Thomas D. Giles, William T. Abraham, John B. Kostis, 1999 .

Inhibition of apoptosis after ischemia-reperfusion in rat myocardium by cycloheximide.

J. Docherty, B. Jugdutt, H. E. Gunter, 1999, Journal of molecular and cellular cardiology.

Functional impact of remodeling therapy with captopril and nitroglycerin during healing after acute myocardial infarction in the dog

B. Jugdutt, M. Khan, Jack Demare, 1991 .

Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKCε Proteins and cGMP

B. Jugdutt, R. Moudgil, V. Menon, 2000, Journal of cardiovascular pharmacology and therapeutics.

Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support.

B. Jugdutt, C. Butler, 2007, Journal of the American College of Cardiology.

Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways.

B. Jugdutt, 2003, Current drug targets. Cardiovascular & haematological disorders.

Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology.

B. Jugdutt, 2011, Journal of the American College of Cardiology.

Preventing adverse remodeling and rupture during healing after myocardial infarction in mice and humans.

B. Jugdutt, 2010, Circulation.

AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.

J. Dyck, B. Jugdutt, G. Lopaschuk, 2002, American journal of physiology. Heart and circulatory physiology.

Expanding Saga of the Renin-Angiotensin System: The Angiotensin II Counter-Regulatory AT2 Receptor Pathway.

B. Jugdutt, 2015, Circulation.

Intravenous Nitroglycerin in Acute Myocardial Infarction

B. Jugdutt, 1991 .

Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension.

B. Jugdutt, 1983, Circulation.

Effect of Intravenous Nitroglycerin on Collateral Blood Flow and Infarct Size in the Conscious Dog

L. Becker, G. Hutchins, B. Bulkley, 1981, Circulation.

The continuing saga of aging and heart failure

B. Jugdutt, 2012, Heart Failure Reviews.

Different relations between infarct size and occluded bed size in barbiturate-anesthetized versus conscious dogs.

B. Jugdutt, Christine Wortman, Marie Riesel, 1985, Journal of the American College of Cardiology.

Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets.

B. Jugdutt, 2008, Current drug targets.

The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI.

K. Dickstein, K. Godang, B. Jugdutt, 2014, European heart journal.

Enhanced Expression of Angiotensin II Type 2 Receptor, Inositol 1,4,5-Trisphosphate Receptor, and Protein Kinase C&egr; During Cardioprotection Induced by Angiotensin II Type 2 Receptor Blockade

B. Jugdutt, A. Clanachan, Y. Xu, 2000, Hypertension.

Myocardial salvage, AT1-receptor blockade, AT2-receptor activation and coronary collaterals.

B. Jugdutt, R. Moudgil, 1999, Journal of the American College of Cardiology.

Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.

B. Jugdutt, 2007, Circulation.

Salvage of Ischemic Myocardium by Dipyridamole in the Conscious Dog

L. Becker, G. Hutchins, B. Jugdutt, 1981, Circulation.

Can Yoga and Physiotherapy Benefit Patients in Weight Loss Programs and with ALS?

B. Jugdutt, 2018, Journal of Yoga and Physiotherapy.

AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: Detection using proteomics

B. Jugdutt, G. Sawicki, 2006, Molecular and Cellular Biochemistry.

Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion

B. Jugdutt, W. Ford, Dinender Kumar, 2004, Molecular and Cellular Biochemistry.

Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts

B. Jugdutt, W. Ford, Dinender Kumar, 2003, Journal of cardiovascular pharmacology and therapeutics.

Enhanced regional AT2-receptor and PKCε expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction

M. Balghith, B. Jugdutt, 2001 .

Effect of Chronic AT1 Receptor Antagonism on Postischemic Functional Recovery and AT1/AT2 Receptor Proteins in Isolated Working Rat Hearts

B. Jugdutt, R. Moudgil, Y. Xu, 2001, Journal of cardiovascular pharmacology and therapeutics.

Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor

M. Balghith, B. Jugdutt, V. Menon, 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Efficacy of Pretreatment With the Angiotensin II Type 1 Receptor Blocker UP269-6 and Losartan in the Dog: Effect on Hemodynamics and Ischemia-Reperfusion

B. Jugdutt, D. O'brien, Y. Xu, 2000, Journal of cardiovascular pharmacology and therapeutics.

Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function.

B. Jugdutt, G. Lopaschuk, R. Schulz, 1998, American journal of physiology. Heart and circulatory physiology.

Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.

B. Jugdutt, W. Ford, A. Clanachan, 1996, Circulation.

Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog.

L. Becker, G. Hutchins, B. Bulkley, 1980, The American journal of cardiology.

Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia‐reperfusion injury: Functional proteomics studies

B. Jugdutt, G. Sawicki, Bodh I. Jugdutt, 2004, Proteomics.

Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog.

B. Jugdutt, 1987, Canadian journal of physiology and pharmacology.

Ischemic ventricular fibrillation: the importance of being spontaneous.

B. Bulkley, J. Brinker, B. Jugdutt, 1981, The American journal of cardiology.

Laser-induced fluorescence: quantitative analysis of atherosclerotic plaque chemical content in human aorta

John Tulip, David S. Wishart, Alexandra Lucas, 1996, Photonics West.

Acromegaly, the systolic click syndrome, and group D streptococcal endocarditis.

B. Jugdutt, H. Freeman, C. Basualdo, 1976, Chest.

Influence of β‐adrenoceptor tone on the cardioprotective efficacy of adenosine A1 receptor activation in isolated working rat hearts

B. Jugdutt, G. Lopaschuk, R. Schulz, 2000, British journal of pharmacology.

Nitroglycerin in acute myocardial infarction.

B. Jugdutt, 1989, The Medical letter on drugs and therapeutics.

Electrophysiologic properties and ventricular fibrillation in normal and myopathic hearts

F. Witkowski, J. Saffitz, B. Jugdutt, 1999 .

The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities

D. Brenner, K. Brown, L. Richeldi, 2019, The American journal of the medical sciences.

CHAPTER 13 – Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction

B. Jugdutt, W. Tymchak, J. Man, 2010 .

Apoptosis and oncosis in acute coronary syndromes: Assessment and implications

B. Jugdutt, H. Idikio, 2005, Molecular and Cellular Biochemistry.

Apoptosis and oxidants in the heart.

B. Jugdutt, Dinender Kumar, 2003, The Journal of laboratory and clinical medicine.

Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

B. Jugdutt, Bodh I Jugdutt, 2003, Circulation.

Detection of Viability of Dysfunctional Myocardium in Coronary Heart Disease. II. Echocardiography

B. Jugdutt, D. Humen, D. Manyari, 1998, Heart Failure Reviews.

The Role of Nitric Oxide in Heart Failure

B. Jugdutt, 2004, Springer US.

Atrial Fibrillation and Heart Failure in the Aging Population

B. Jugdutt, P. Kazemian, 2014 .

Two-dimensional echocardiographic detection of left pulmonary artery aneurysm following Potts' anastomosis.

R. L. Fortune, B. Jugdutt, R. Taylor, 1983, Chest.

Atrial fibrillation and heart failure in the elderly

B. Jugdutt, G. Oudit, P. Kazemian, 2012, Heart Failure Reviews.

Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Outcomes

B. Jugdutt, N. Sharma, S. Abualnaja, 2014 .

STEMI and heart failure in the elderly: role of adverse remodeling

B. Jugdutt, A. Jelani, 2010, Heart Failure Reviews.

Biology of Aging and Implications for Heart Failure Therapy and Prevention

B. Jugdutt, 2014 .

Oxidative Stress and Heart Failure

B. Jugdutt, B. A. Jugdutt, 2019, Modulation of Oxidative Stress in Heart Disease.

B. Jugdutt, 2015 .

Changing Demographics of the Aging Population with Heart Failure and Implications for Therapy

B. Jugdutt, 2014 .

Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy

B. Jugdutt, 2014 .

Heart failure in the elderly: advances and challenges

B. Jugdutt, 2010, Expert review of cardiovascular therapy.

Aging and heart failure: changing demographics and implications for therapy in the elderly

Bodh I. Jugdutt, B. Jugdutt, 2010, Heart Failure Reviews.

Cardiac tamponade as the first clinical manifestation of metastatic adenocarcinoma of the lung.

D. Taylor, M. Balghith, B. Jugdutt, 2000, The Canadian journal of cardiology.

Prostaglandin inhibition increases infarct size after coronary artery occlusion in conscious dogs

L. Becker, G. Hutchins, B. Bulkley, 1978 .

Modification of left ventricular geometry and function during healing after acute myocardial infarction

B. Jugdutt, 2006 .

Apoptosis after reperfused myocardial infarction: Role of angiotensin II.

B. Jugdutt, 2004, Experimental and clinical cardiology.

Valsartan in the Treatment of Heart Attack Survivors

B. Jugdutt, 2006, Vascular health and risk management.

Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart

B. Jugdutt, G. Moe, Peter P. Liu, 2008, Molecular and Cellular Biochemistry.

Extracellular Matrix and Cardiac Remodeling

B. Jugdutt, 2005 .

Systolic heart failure in the elderly: optimizing medical management

Bodh I. Jugdutt, B. Jugdutt, Jonathan P. Man, 2012, Heart Failure Reviews.

Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly

B. Jugdutt, 2010, Clinical interventions in aging.

Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly

B. Jugdutt, 2008, Heart Failure Reviews.

AT1 Receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction

B. Jugdutt, V. Menon, 2004, Molecular and Cellular Biochemistry.

The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly

B. Jugdutt, C. Butler, 2012, Heart Failure Reviews.

Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters

B. Jugdutt, V. Menon, 2002, Journal of cardiovascular pharmacology and therapeutics.

When Is Enough Enough? Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix :

B. Jugdutt, 2011 .

Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm.

K. Bainey, B. Jugdutt, 2009, Atherosclerosis.

Prevention of ventricular remodeling after myocardial infarction and in congestive heart failure

B. Jugdutt, 1996, Heart Failure Reviews.

Aging and Markers of Adverse Remodeling After Myocardial Infarction

B. Jugdutt, A. Jelani, 2013 .

Nitrates and Left Ventricular Remodeling

B. Jugdutt, 1998 .

AT1receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: Detection using proteomics

B. Jugdutt, G. Sawicki, 2004, Molecular and Cellular Biochemistry.

Detection of Viability of Dysfunctional Myocardium in Coronary Heart Disease. I. Radionuclide Imaging

B. Jugdutt, D. Humen, D. Manyari, 1998, Heart Failure Reviews.

Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.

B. Jugdutt, B. Jugdutt, J. Warnica, 1988, Circulation.

Two‐dimensional Echocardiography and Infarct Size: Relationship of Regional Wall Motion and Thickening to the Extent of Myocardial Infarction in the Dog

G M Hutchins, J. Weiss, M. Weisfeldt, 1981, Circulation.

Effect of nitrates on myocardial remodeling after acute myocardial infarction.

B. Jugdutt, 1996, The American journal of cardiology.

Regulation of Fibrosis After Myocardial Infarction: Implications for Ventricular Remodeling

B. Jugdutt, 2013 .

Modulators of Remodeling After Myocardial Infarction

B. Jugdutt, 2011 .

Proteases as Potential Targets in Left Ventricular Remodeling After Myocardial Infarction

B. Jugdutt, 2014 .

Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling

B. Jugdutt, J. Wong, 2014 .

Aging and Optimal Therapy of Systolic Heart Failure in the Elderly

B. Jugdutt, N. Sharma, 2014 .

Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs

B. Jugdutt, H. Idikio, R. Uwiera, 2009, Molecular and Cellular Biochemistry.

Aging and defective healing, adverse remodeling, and blunted post-conditioning in the reperfused wounded heart.

B. Jugdutt, A. Jelani, 2008, Journal of the American College of Cardiology.

Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction

B. Jugdutt, H. Idikio, R. Uwiera, 2008, Molecular and Cellular Biochemistry.

Valsartan reverses post‐translational modifications of the δ‐subunit of ATP synthase during in vivo canine reperfused myocardial infarction

B. Jugdutt, G. Sawicki, 2007, Proteomics.

Prevention of heart failure in the elderly: when, where and how to begin?

B. Jugdutt, 2012, Heart Failure Reviews.

Cardiac Remodeling

N. Dhalla, B. Jugdutt, 2013, Advances in Biochemistry in Health and Disease.

Opposite effects of amlodipine and enalapril on infarct collagen and remodelling during healing after reperfused myocardial infarction.

B. Jugdutt, S. Musat-Marcu, 2000, Canadian Journal of Cardiology.

Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures

B. Jugdutt, H. Idikio, R. Uwiera, 2007, Molecular and Cellular Biochemistry.

Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography.

B. Jugdutt, B. Jugdutt, R. Amy, 1986, Journal of the American College of Cardiology.

Limiting fibrosis after myocardial infarction.

B. Jugdutt, Bodh I Jugdutt, 2009, The New England journal of medicine.

Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade.

B. Jugdutt, G. Sawicki, V. Menon, 2004, Journal of cardiac failure.

Nitric Oxide in Heart Failure: Friend or Foe

B. Jugdutt, 2002, Heart Failure Reviews.

Fine-tuning blood pressure control to minimize cardiovascular risk.

B. Jugdutt, 2007, Preventive cardiology.

B. Jugdutt, H. Idikio, R. Uwiera, 2013, Molecular and Cellular Biochemistry.

Differential morphometric and ultrastructural remodelling in the left atrium and left ventricle in rapid ventricular pacing-induced heart failure.

B. Jugdutt, H. Idikio, P. Scott, 2000, The Canadian journal of cardiology.

Nature of the border zone of myocardial ischemia after coronary artery occlusion in the dog

L. Becker, B. Jugdutt, 1977 .

Reduction of infarct size by intravenous nitroglycerin infusion in conscious dogs

L. Becker, G. Hutchins, B. Bulkley, 1978 .

Deterring myocardial infarct expansion

B. Jugdutt, B. Michorowski, M. Senaratne, 1987 .

Exercise training after anterior Q wave myocardial infarction: importance of regional left ventricular function and topography.

B. Jugdutt, B. Jugdutt, B. Michorowski, 1988, Journal of the American College of Cardiology.

Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.

B. Jugdutt, B. Jugdutt, B I Jugdutt, 1996, Circulation.

Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling.

B. Jugdutt, B. Jugdutt, C. Basualdo, 1989, The Canadian journal of cardiology.

Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction.

B. Jugdutt, B. Jugdutt, J. Warnica, 1989, The American journal of cardiology.

Hepatic artery ligation in treatment of carcinoid syndrome.

B. Jugdutt, F. W. Turner, M. Watanabe, 1975, Canadian Medical Association journal.

Cardiac Remodeling

N. Dhalla, B. Jugdutt, 2013, Advances in Biochemistry in Health and Disease.

Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.

B. Jugdutt, B. Jugdutt, 1995, Journal of the American College of Cardiology.

Prostaglandins in myocardial: with emphasis on myocardial preservation.

B. Jugdutt, 1981, Prostaglandins and medicine.

B. Jugdutt, H. Idikio, V. Menon, 2010, Circulation.

The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities

D. Brenner, K. Brown, L. Richeldi, 2019, The American journal of the medical sciences.

Consensus recommendations for the management of chronic heart failure: Introduction

R. Falk, G. Fonarow, P. Kowey, 1999 .

Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support.

B. Jugdutt, C. Butler, 2007, Journal of the American College of Cardiology.

Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog.

B. Jugdutt, W. Ford, M. Khan, 1998, The Canadian journal of cardiology.